{
    "other_tests": [
        {
            "procedure_name": "Serum Carbamazepine Level Monitoring",
            "date": "Not specified",
            "findings": "Consistently ran between 7.0 and 8.3 µg/ml prior to nefazodone introduction; elevated to 10.8 µg/ml after nefazodone initiation.",
            "changes_over_time": "After reducing carbamazepine dose by 200 mg, the serum level decreased to 10.2 µg/ml one week later; further reduction led to a final level of 7.4 µg/ml."
        },
        {
            "procedure_name": "Serum Carbamazepine Level Monitoring",
            "date": "Not specified",
            "findings": "Serum levels ranged between 5.2 and 6.2 µg/ml before nefazodone introduction; elevated to 15.1 µg/ml 14 days after starting nefazodone.",
            "changes_over_time": "After reducing carbamazepine dose to 200 mg t.i.d., serum level fell to 5.8 µg/ml within 5 days."
        }
    ]
}